Eelgrass (Zostera marina)

Eelgrass (Zostera marina) is a marine flowering plant with no documented health benefits for human consumption. Research indicates significant heavy metal bioaccumulation, particularly cadmium with bioconcentration factors up to 10.25, raising contamination concerns.

Origin & History

Eelgrass (Zostera marina) is a perennial marine angiosperm that forms extensive underwater meadows in temperate coastal waters of the North Pacific and Atlantic Oceans. It grows from rhizomes with ribbon-like leaves and serves as a foundational species in coastal ecosystems. No standardized extraction methods for biomedical use have been developed, with current analyses focused on environmental monitoring using acid digestion and ICP-MS techniques.

Historical & Cultural Context

No evidence of historical or traditional medicinal use in any medical systems including Ayurveda, Traditional Chinese Medicine, or Indigenous practices was found. Zostera marina is valued solely for its ecological role in habitat provision, carbon sequestration, and fisheries support rather than therapeutic applications.

Health Benefits

• No documented health benefits - research focuses exclusively on ecological monitoring
• Environmental studies show bioaccumulation of heavy metals (Cd BCF up to 10.25), indicating potential contamination risks rather than benefits
• Nutrient content includes 29-40.9% carbon and 1.13-3.79% nitrogen by dry weight, but no therapeutic applications studied
• Higher zinc and copper concentrations found in leaves versus roots, but no biomedical significance established
• No evidence of antioxidant, anti-inflammatory, or other therapeutic properties in available research

How It Works

Eelgrass does not demonstrate beneficial mechanisms of action for human health. Instead, the plant exhibits bioaccumulation of toxic heavy metals including cadmium, lead, and mercury through root uptake and foliar absorption from contaminated marine environments. This bioaccumulation occurs via metal-binding proteins and occurs without detoxification pathways.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on Zostera marina were identified in the literature. All available research focuses on environmental monitoring, heavy metal bioaccumulation, and ecosystem responses to nutrient enrichment. No PubMed PMIDs are available for biomedical applications.

Clinical Summary

No clinical trials have been conducted on eelgrass for human health benefits. Available research consists entirely of environmental monitoring studies focusing on heavy metal contamination in marine ecosystems. Environmental studies consistently show concerning levels of cadmium bioaccumulation with bioconcentration factors reaching 10.25 in contaminated areas. The absence of toxicological studies means safety profiles for human consumption remain completely unknown.

Nutritional Profile

Macronutrients (dry weight basis): Carbon 29-40.9%, Nitrogen 1.13-3.79% (corresponding to estimated crude protein 7-24% via N×6.25 conversion), with carbohydrate content primarily as structural polysaccharides including cellulose and hemicellulose. Fiber: High insoluble fiber content typical of seagrasses; contains sulfated polysaccharides and starch-like storage glucans in rhizomes. Minerals: Zinc and copper present at elevated concentrations relative to surrounding sediment; cadmium bioconcentration factor (BCF) up to 10.25 indicating significant Cd accumulation from environment (exact ppm varies by habitat); also accumulates lead, iron, and manganese from sediment. Bioactive compounds: Contains phenolic acids including caffeic acid derivatives and rosmarinic acid analogs; flavonoids including luteolin and apigenin glycosides documented in Zostera species; sulfated flavones reported. Pigments: Chlorophyll a and b, beta-carotene, and fucoxanthin-related carotenoids present in leaf tissue. Lipids: Low total lipid content (approximately 1-3% DW); polyunsaturated fatty acids present including omega-3 fatty acids (ALA), though at lower concentrations than marine macroalgae. Bioavailability note: Heavy metal accumulation (particularly Cd) presents a significant contamination concern that would substantially limit any safe human consumption application; nutritional compounds have not been studied for bioavailability in human or animal models.

Preparation & Dosage

No clinically studied dosages exist as no human trials or therapeutic uses have been documented. Environmental studies report nutrient parameters in mesocosms (7-10 μM NO₃⁻ + NO₂⁻, 2-10 μM NH₄⁺) but these relate to ecosystem research, not medicinal preparations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - no biomedical uses established

Safety & Interactions

Eelgrass consumption poses potential heavy metal toxicity risks due to documented cadmium, lead, and mercury bioaccumulation. No safety data exists for human consumption, drug interactions, or appropriate dosing guidelines. Pregnant and breastfeeding women should avoid consumption due to unknown teratogenic effects of accumulated heavy metals. The plant's role as a bioaccumulator of marine pollutants makes it unsuitable for dietary supplementation.